Development of TLR7/8 small RNA antagonists

Area of Science:

• Immunology
• Molecular Biology
• RNA Therapeutics

Background:

• Toll-like receptors (TLRs) are crucial for innate immunity, recognizing microbial structures.
• TLR7 and TLR8 specifically detect viral RNA, but can also target self-RNA, contributing to autoimmune diseases.
• Current research explores RNA modifications for immune modulation.

Purpose of the Study:

• To characterize immunosuppressive RNA oligonucleotides.
• To investigate the role of 2'-modifications in RNA in immune evasion and TLR suppression.
• To explore the therapeutic potential of modified RNAs in autoimmune conditions.

Main Methods:

• Synthesis of RNA oligonucleotides with 2'-modified uridines.
• Assays to evaluate immune activation by modified RNAs.
• Assessment of TLR7 and TLR8 signaling suppression by modified RNAs.

Main Results:

• Incorporation of 2'-modifications in RNA prevents immune activation.
• These modifications effectively suppress TLR7 and TLR8 signaling triggered by immunostimulatory RNAs.
• 2'-modified RNAs demonstrate immunosuppressive properties comparable to DNA oligonucleotides.

Conclusions:

• 2'-modified RNA oligonucleotides can evade innate immune detection.
• These modified RNAs act as potent suppressors of TLR7 and TLR8-mediated immune responses.
• Modified RNAs hold promise as inhibitors of TLR-driven autoimmune diseases and inflammatory conditions.